Successful donor-lymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotype

Bone Marrow Transplantation

Volumn 42, Issue 3, 2008, Pages 219-220

  Kordes, U ^a   Binder, T M C ^a   Eiermann, T H ^a   Hassenpflug Diedrich, B ^b   Hassan, M A ^a   Beutel, K ^a   Nagy, M ^c   Kabisch, H ^a   Schneppenheim, R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; BUSULFAN; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C3D; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IRON CHELATING AGENT; METHOTREXATE; MICROSATELLITE DNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; THYMOCYTE ANTIBODY; VINCRISTINE;

ACANTHOCYTOSIS; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW TRANSPLANTATION; CASE REPORT; CHIMERA; CHRONIC GRANULOMATOUS DISEASE; DONOR LYMPHOCYTE INFUSION; DRUG WITHDRAWAL; ENGRAFTMENT; ERYTHROCYTE TRANSFUSION; EXON; GENE DELETION; GENE MAPPING; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LETTER; LEUKOCYTE; LIVER ABSCESS; LUNG ASPERGILLOSIS; MALE; MCLEOD SYNDROME; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE COUNT; X CHROMOSOME LINKED DISORDER;

BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, X; DYNEIN ATPASE; EXONS; GRANULOMATOUS DISEASE, CHRONIC; HEMOLYSIS; HUMANS; LYMPHOCYTE TRANSFUSION; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; SEQUENCE DELETION;

EID: 50049115781     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.159     Document Type: Letter

References (10)

1. Massenkeil G, Nagy M, Lawang M, Rosen O, Genvresse I. Geseric G et al. Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved. Bone Marrow Transplant 2003; 31: 339-345.
2. Daikelei T, Tyndall A. Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 2007; 20: 349-360.
3. Chen X. Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR. Absence of' regulatory T-cell control of THI and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007; 110: 3804-3813.
4. O'Brien TA, Eastlund T, Peters C, Neglia JP, Defor T. Ramsay NKC et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: High incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 2004; 127: 67-75.
5. Drobyski WR, Potluri J, Sauer S, Gottschall JL. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1093-1099.
6. Chen FE, Owen I, Savage D, Roberts I, Apperley I, Goldman JM et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997;19: 491-495.
7. Sanz J, Arriaga, F, Montesinos P, Orti G, Lorenzo I, Cantero S et al. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant 2007; 39: 555-561.
8. Cwynarski K, Goulding R, Pocock C, Dazzi F, Craddock C, Kaeda J et al. Immune haemolytic arriemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: Association with leukaemic relapse and treatment with donor lymphocyte infusions. Bone Marrow Transplant 2001; 28: 581-586.
9. Sokol RJ, Stamps R, Booker JB, Scott FM, Laidlaw, ST, Vandenberghe EA et al. Posttransplant immune-mediated hemolysis. Transfusion 2002; 42: 198-204.
10. Mqadmi A, Zheng X, Yazdanbakhsh K. CD4-CD25-regulatory T cells control induction of autoimmune hemolytic anemia. Blood 2005; 105: 3746-3748.